According to previous research, preoperative CEA levels were complementary to CA19-9 levels in predicting prognosis in patients with resectable ICC [15], and univariate analysis in our study also revealed that evaluated serum CEA levels were related to poor prognosis. The gene discussed is CEACAM5; the disease is intrahepatic cholangiocarcinoma.